Cita APA

Shyr, Y., & Shyr, D. (2020). What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials? JAMA Oncol.

Citación estilo Chicago

Shyr, Yu, y Derek Shyr. "What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?" JAMA Oncol 2020.

Cita MLA

Shyr, Yu, y Derek Shyr. "What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?" JAMA Oncol 2020.